Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-2-24
|
pubmed:abstractText |
The serologic reactivity and epidemiology associated with different hepatitis C virus (HCV) variants were investigated in a cohort of 113 anti-HCV-positive donors. In Scotland, HCV type 1 accounted for one-half of all infections; 40 percent of subjects were infected with HCV type 3, and the remainder were infected with type 2. Reactivity with the NS-4-encoded antigens in the first-generation anti-c100 assay was absent in 68 percent of donors infected with types 2 and 3, as compared with 10 percent for those infected with type 1. Even when combined with surrogate marker testing, first-generation tests would have failed to detect 12 percent of HCV-infected blood donors. The age distribution, incidence of past infection with hepatitis B virus, and reported risk factors were similar in donors infected with types 1 and 3 (mean ages were 31.9 and 29.9; 18 and 17.5% were positive for antibody to hepatitis B core antigen; and 47 and 48% had past intravenous drug abuse). However, the distributions of alanine aminotransferase levels were significantly different in those infected with type 3 (abnormally raised in 83%) and those infected with type 1 (55% abnormal alanine aminotransferase; p < 0.05) or type 2 (60%; p < 0.01) and those who were nonviremic (8%; p < 0.0001). These data suggest that HCV type 1 is the most common HCV infection in blood donors and that infection with HCV type 3 may be associated with more severe liver disease, because of more recent infection or because of a greater inherent pathogenicity of type 3 variants.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0041-1132
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-13
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7678709-Alanine Transaminase,
pubmed-meshheading:7678709-Biological Markers,
pubmed-meshheading:7678709-Blood Donors,
pubmed-meshheading:7678709-Hepacivirus,
pubmed-meshheading:7678709-Hepatitis Antibodies,
pubmed-meshheading:7678709-Hepatitis C,
pubmed-meshheading:7678709-Hepatitis C Antibodies,
pubmed-meshheading:7678709-Humans,
pubmed-meshheading:7678709-Northern Ireland,
pubmed-meshheading:7678709-Polymerase Chain Reaction,
pubmed-meshheading:7678709-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:7678709-RNA, Viral,
pubmed-meshheading:7678709-Scotland,
pubmed-meshheading:7678709-Substance Abuse, Intravenous
|
pubmed:year |
1993
|
pubmed:articleTitle |
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.
|
pubmed:affiliation |
Edinburgh and South East Scotland Blood Transfusion Service.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|